• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money

cafead

Administrator
Staff member
  • cafead   Aug 16, 2022 at 11:02: AM
via Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! Even better, my Freedom of Information Act (FOIA) request was able to pry out detailed purchases by covered entity type.

article source
 

<